The Rho/MRTF-pirin axis: a promising target for overcoming melanoma drug resistance.
作者信息
Chen Xiaoyan, Zhang Junfeng, Zhang Bao, Li Zhi
机构信息
Department of Rehabilitation, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Medical College of Nanchang Institute of Technology, Nanchang, Jiangxi, China.
出版信息
Front Pharmacol. 2025 Jul 16;16:1571933. doi: 10.3389/fphar.2025.1571933. eCollection 2025.
Abstract
摘要
相似文献
1
The Rho/MRTF-pirin axis: a promising target for overcoming melanoma drug resistance.Rho/MRTF-吡啉轴：克服黑色素瘤耐药性的一个有前景的靶点。
Front Pharmacol. 2025 Jul 16;16:1571933. doi: 10.3389/fphar.2025.1571933. eCollection 2025.
2
Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin.Rho/MRTF抑制诱导黑色素瘤细胞凋亡事件及预防耐药性的机制研究：吡咯素参与的意义
Front Pharmacol. 2025 Jan 23;16:1505000. doi: 10.3389/fphar.2025.1505000. eCollection 2025.
3
Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds.鉴定吡啉作为CCG-1423/CCG-203971系列抗纤维化和抗转移化合物的分子靶点。
ACS Pharmacol Transl Sci. 2019 Apr 12;2(2):92-100. doi: 10.1021/acsptsci.8b00048. Epub 2019 Mar 18.
4
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade.抑制 Rho/MRTF 通路可改善 BRAF 耐药性黑色素瘤对 PD1/PDL1 阻断的反应。
Int J Cancer. 2024 Oct 1;155(7):1303-1315. doi: 10.1002/ijc.35056. Epub 2024 Jun 19.
5
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.心肌相关转录因子通路的药理学抑制可阻断RhoC过表达黑色素瘤的肺转移。
Mol Cancer Ther. 2017 Jan;16(1):193-204. doi: 10.1158/1535-7163.MCT-16-0482. Epub 2016 Nov 11.
6
Diverse roles of SARS-CoV-2 Spike and Nucleocapsid proteins in EndMT stimulation through the TGF-β-MRTF axis inhibited by aspirin.SARS-CoV-2 刺突蛋白和核衣壳蛋白通过 TGF-β-MRTF 轴在血管内皮-间充质转化中的不同作用被阿司匹林抑制。
Cell Commun Signal. 2024 May 28;22(1):296. doi: 10.1186/s12964-024-01665-z.
7
Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation.Rho/MRTF 在侵袭性vemurafenib 耐药的鼠黑素瘤中的作用及其对免疫检查点的调控。
Int J Mol Sci. 2023 Sep 7;24(18):13785. doi: 10.3390/ijms241813785.
8
Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in -Mutant Melanoma Cell Lines.抑制心肌素相关转录因子途径可提高曲美替尼在BRAF突变黑色素瘤细胞系中的疗效。
Cancers (Basel). 2021 Apr 22;13(9):2012. doi: 10.3390/cancers13092012.
9
A small-molecule inhibitor shows that pirin regulates migration of melanoma cells.小分子抑制剂表明，Pirin 调节黑色素瘤细胞的迁移。
Nat Chem Biol. 2010 Sep;6(9):667-73. doi: 10.1038/nchembio.423. Epub 2010 Aug 15.
10
miR-10a-5p inhibits cardiac fibrosis by targeting the MRTF-A/TGF-β2 feedback loop.微小RNA-10a-5p通过靶向MRTF-A/转化生长因子-β2反馈环抑制心脏纤维化。
Cell Signal. 2025 Nov;135:111981. doi: 10.1016/j.cellsig.2025.111981. Epub 2025 Jul 8.
本文引用的文献
1
The novel HDAC6 inhibitor 9r induces anti-tumor responses by enhancing T cell response and inducing MHC class II signaling pathways in esophageal cancer.新型组蛋白去乙酰化酶6（HDAC6）抑制剂9r通过增强T细胞反应和诱导食管癌中的主要组织相容性复合体II类（MHC II）信号通路来诱导抗肿瘤反应。
Int Immunopharmacol. 2025 Aug 28;161:115076. doi: 10.1016/j.intimp.2025.115076. Epub 2025 Jun 14.
2
NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1 Mutant Melanoma.NF1缺失促进EGFR激活并使NF1突变型黑色素瘤对EGFR抑制敏感。
Cancer Res. 2025 Jun 10. doi: 10.1158/0008-5472.CAN-24-3904.
3
SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression.SMARCA4通过抑制RHOA抑制乳腺癌进展和转移。
Cancer Res. 2025 May 15;85(10):1803-1818. doi: 10.1158/0008-5472.CAN-24-2801.
4
Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin.Rho/MRTF抑制诱导黑色素瘤细胞凋亡事件及预防耐药性的机制研究：吡咯素参与的意义
Front Pharmacol. 2025 Jan 23;16:1505000. doi: 10.3389/fphar.2025.1505000. eCollection 2025.
5
Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design.通过三维定量构效关系和分子对接研究开发新型ROCK抑制剂：多靶点药物设计框架
Pharmaceutics. 2024 Sep 26;16(10):1250. doi: 10.3390/pharmaceutics16101250.
6
Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication.评估铁死亡作为转移性葡萄膜黑色素瘤治疗和预后的一个有前景的候选因素。
Front Pharmacol. 2024 Oct 1;15:1466896. doi: 10.3389/fphar.2024.1466896. eCollection 2024.
7
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours.实体瘤免疫检查点抑制的外周免疫生物标志物。
Clin Transl Med. 2024 Aug;14(8):e1814. doi: 10.1002/ctm2.1814.
8
Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation.Rho/MRTF 在侵袭性vemurafenib 耐药的鼠黑素瘤中的作用及其对免疫检查点的调控。
Int J Mol Sci. 2023 Sep 7;24(18):13785. doi: 10.3390/ijms241813785.
9
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.黑色素瘤中免疫检查点阻断耐药的分子和功能全景。
Nat Commun. 2023 Mar 18;14(1):1516. doi: 10.1038/s41467-023-36979-y.
10
Cutaneous melanoma metastases: Clinical and dermoscopic findings.皮肤黑色素瘤转移：临床及皮肤镜检查结果
J Eur Acad Dermatol Venereol. 2023 May;37(5):941-944. doi: 10.1111/jdv.18701. Epub 2022 Nov 5.
Zotero 插件